Stock Market Today 08.01.2026
LIVEMarkets rolling coverageStarted: January 8, 2026, 12:00 AM ESTUpdated: January 8, 2026, 11:59 PM EST Royalty Pharma Undervalued on DCF Despite 1-Year Rally (RPRX) January 8, 2026, 11:59 PM EST. RPRX trades at $40.26, after a 40% return in the last year. A Discounted Cash Flow model-using a 2-stage Free Cash Flow to Equity framework-yields an intrinsic value around $179.83 a share, implying the stock is about 77.6% undervalued versus today. The model assumes TTM FCF of roughly $429.4 million and forecasts growth to about $4.2 billion by 2030. On a multiples basis, the stock trades at P/E 22.49x, above
